Cipla | CIPLA - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Arca Biopharma USD 2.23M 1.08M 2025-12
aTyr Pharma USD 82.26M 77.46M 2025-12
Bio Path USD 199K 300K 2025-09
Brainstorm Cell Therapeutics USD 1.39M 326K 2025-12
Capricor Therapeutics USD 1.92M 446.47K 2025-12
Cara Therapeutics USD 2.19M 2.45M 2025-09
Cipla INR 13.25B 101.8M 2025-12
Dr.Reddys Laboratories INR 26.92B 482M 2025-12
Esperion Therapeutics USD 39.42M 456K 2025-12
Immunic USD 3.45M 451K 2025-12
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
TherapeuticsMD USD 1.23M 90K 2024-06
UPL INR 15.8B 660M 2025-09